Boston Scientific Corporation company logo

# 1st Gen Model Boston Scientific Corporation Surgical & medical instruments

Subscribe >> Deal exit on
Dec. 15, 2017
Deal entry on
Dec. 15, 2017
1.65%Expected margin
66.10% successful of 59 deals
$25.62 Last close price
at 14-dec-2017


Model's trade recommendations -1.67% Return for period

5.93% Annual return

$35.30B Market Cap

β 0.96  


Model (following trade recommendations)


Underlying stock

S&P 500

Return for period -1.67%
52wk return 6.04%
52wk Range
Sortino ratio 0.91
Sharpe ratio 0.62
Norm. RMSE 0.67%
Downside risk 6.48%
Volatility 9.41%
  • STRONG BUY Analysts consensus recommendation

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: Cardiovascular, Rhythm Management, and MedSurg. The company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; other coronary therapy products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as certain peripheral vessels; and structural heart therapy systems. It also provides stents, balloon catheters, wires, peripheral embolization devices, and vena cava filters used to treat peripheral arterial disease; and biliary stents, drainage catheters, and micro-puncture sets to treat, diagnose, and ease benign and malignant tumors.

Industry sector: Medical

Sector classification: Surgical & medical instruments

Deep Learning based analysis and prediction model for Boston Scientific Corporation (BSX) stock is a 1st Generation Non-linear Autoregresive with exogenous variable(s) (NARX) model based on the Recurrent Neural Network architecture.

Model is in the production pipeline since Sept. 30, 2015.

Market data for BSX model training are being downloaded from the Quandl premium datasets on a daily basis.

Model is being retrained on a daily basis.

Float 1363M
P/E 21.07
Shares Outstanding 1373M
% Held by Insiders 0.74%
% Held by Institutions 90.57%
EPS (last reported FY) $1.11
EPS (last reported Q) $0.31
EPS, estimated (last reported Q) $0.31
Total revenues $8 B
Net income $0 B